These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12690651)

  • 21. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.
    Candler PM; Hart PE; Barnett M; Weil R; Rees JH
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1411-5. PubMed ID: 15377687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraneoplastic Neurologic Syndromes.
    Rosenfeld MR; Dalmau J
    Neurol Clin; 2018 Aug; 36(3):675-685. PubMed ID: 30072076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunopathogenesis of paraneoplastic neurological syndromes.
    Sutton I; Winer JB
    Clin Sci (Lond); 2002 May; 102(5):475-86. PubMed ID: 11980564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on paraneoplastic and autoimmune disorders of the central nervous system.
    Rosenfeld MR; Dalmau J
    Semin Neurol; 2010 Jul; 30(3):320-31. PubMed ID: 20577938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoimmune mechanisms in paraneoplastic neurological diseases: the paradigm of opsoclonus myoclonus ataxia syndrome].
    Ovadia H; Karussis D; Abramsky O
    Harefuah; 2006 Apr; 145(4):298-303, 317. PubMed ID: 16642634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraneoplastic nerve hyperexcitability.
    Liebenthal JA; Rezania K; Nicholas MK; Lukas RV
    Neurol Res; 2015 Jun; 37(6):553-9. PubMed ID: 25591423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paraneoplastic syndromes of the central nervous system].
    Silvestris N; Lucarelli A; Scaringella P; Di Ciaula A; Ambrosini S; Fata L
    Clin Ter; 2000; 151(4):279-82. PubMed ID: 11107677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic syndromes affecting the nervous system.
    Darnell RB; Posner JB
    Semin Oncol; 2006 Jun; 33(3):270-98. PubMed ID: 16769417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Paraneoplastic neurological syndromes].
    Antoine JC; Camdessanché JP
    Presse Med; 2007 Oct; 36(10 Pt 2):1418-26. PubMed ID: 17399944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurologic complications of systemic cancer.
    Cascino TL
    Med Clin North Am; 1993 Jan; 77(1):265-78. PubMed ID: 8419722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Paraneoplastic neurological syndromes].
    Rauer S
    Fortschr Neurol Psychiatr; 2011 Jan; 79(1):51-8; quiz 59-61. PubMed ID: 21240836
    [No Abstract]   [Full Text] [Related]  

  • 34. Navigating the paraneoplastic neurological syndromes.
    Giannopoulou C
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):333-8. PubMed ID: 12722733
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on paraneoplastic syndromes.
    Dropcho EJ
    Curr Opin Neurol; 2005 Jun; 18(3):331-6. PubMed ID: 15891421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in diagnosis of and therapy for paraneoplastic neurological syndrome of central nervous system].
    Kawanani T; Katou T
    Nihon Naika Gakkai Zasshi; 2008 Aug; 97(8):1764-70. PubMed ID: 18833673
    [No Abstract]   [Full Text] [Related]  

  • 37. Childhood opsoclonus myoclonus.
    Dale RC
    Lancet Neurol; 2003 May; 2(5):270. PubMed ID: 12849175
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent advance in immunological tests in paraneoplastic neurological syndrome.
    Fong CS
    Acta Neurol Taiwan; 2005 Mar; 14(1):28-35. PubMed ID: 15835287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New concepts in paraneoplastic neurological syndromes.
    Honnorat J; Viaccoz A
    Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.